HW
COLL icon

Hancock Whitney’s Collegium Pharmaceutical COLL Stock Holding History

Hancock Whitney’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,764
Closed -$516K – 827
2021
Q1 		$516K Buy
21,764
+2,965
+16% +$70.4K 0.02% 532
2020
Q4 		$377K Buy
18,799
+2,429
+15% +$47.4K 0.01% 608
2020
Q3 		$341K Sell
16,370
-5,757
-26% -$104K 0.01% 595
2020
Q2 		$387K Buy
22,127
+325
+1% +$6.36K 0.01% 563
2020
Q1 		$356K Buy
21,802
+5,102
+31% +$105K 0.01% 584
2019
Q4 		$344K Buy
+16,700
New +$278K 0.01% 644

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Hancock Whitney's COLL Position: Q2 2021 in Review

Hancock Whitney sold out of Collegium Pharmaceutical (COLL) in Q2 2021, closing a stake of 21,764 shares — an estimated $516K sold.

Hancock Whitney first reported a position in COLL in Q4 2019 and held it in 6 quarters. The position peaked at $516K in Q1 2021. 158 funds tracked by Wall St. Rank hold COLL as of Q2 2021.

  • Hancock Whitney reported no remaining Collegium Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Hancock Whitney sold 21,764 Collegium Pharmaceutical shares in Q2 2021, an estimated $516K.
  • Hancock Whitney first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 6 quarters.
  • Hancock Whitney's Collegium Pharmaceutical position peaked at $516K in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2021.

Based on Hancock Whitney's 13F filing for Q2 2021, filed 9 Aug 2021.